Efficacy of oral prednisolone and dexamethasone in horses with recurrent airway obstruction in the presence of continuous antigen exposure

Equine Veterinary Journal

Volumn 42, Issue 4, 2010, Pages 316-321

  Leclere, M ^a   Lefebvre Lavoie, J ^a   Beauchamp, G ^b   Lavoie, J P ^a  

^a Clinical Sciences Department   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Airway inflammation; Corticosteroids; Cortisol; Heaves; Horse; Pulmonary function

Indexed keywords

ANTIGEN; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; PREDNISOLONE;

ANIMAL; ANIMAL DISEASE; ANIMAL HOUSING; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HORSE; HORSE DISEASE; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS; CROSS-OVER STUDIES; DEXAMETHASONE; FEMALE; HORSE DISEASES; HORSES; HOUSING, ANIMAL; LUNG DISEASES, OBSTRUCTIVE; MALE; PREDNISOLONE;

EQUIDAE;

EID: 77952791210     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/j.2042-3306.2009.00022.x     Document Type: Article

References (26)

1. Ainsworth DM. Recurrent airway obstruction. Large Animal Internal Medicine 2009, 556-562. Smith BP. In, 4th, edn., Ed, Mosby Elsevier, St. Louis, pp
2. Baid SK, Nieman LK. Therapeutic doses of glucocorticoids: Implications for oral medicine. Oral Dis. 2006, 12:436-442.
3. Beech J. Chronic obstructive pulmonary disease. Vet. Clin. N. Am.: Equine Pract. 1991, 7:79-91.
4. Cesarini C, Hamilton E, Picandet V, Lavoie JP. Theophylline does not potentiate the effects of a low dose of dexamethasone in horses with recurrent airway obstruction. Equine vet. J. 2006, 38:570-573.
5. Cohen ND, Carter GK. Steroid hepatopathy in a horse with glucocorticoid-induced hyperadrenocorticism. J. Am. vet. med. Ass. 1992, 200:1682-1684.
6. Cornelisse CJ, Robinson NE, Berney CE, Kobe CA, Boruta DT, Derksen FJ. Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction. Equine vet. J. 2004, 36:426-430.
7. Couetil LL, Chilcoat CD, DeNicola DB, Clark SP, Glickman NW, Glickman LT. Randomized, controlled study of inhaled fluticasone propionate, oral administration of prednisone, and environmental management of horses with recurrent airway obstruction. Am. J. vet. Res. 2005, 66:1665-1674.
8. Couroucé-Malblanc A, Fortier G, Pronost S, Siliart B, Brachet G. Comparison of prednisolone and dexamethasone effects in the presence of environmental control in heaves-affected horses. Vet. J. 2008, 175:227-233.
9. Cunningham FE, Rogers S, Fischer JH, Jensen RC. The pharmacokinetics of dexamethasone in the thoroughbred racehorse. J. vet. Pharmacol. Ther. 1996, 19:68-71.
10. DeLuca L, Erb HN, Young JC, Perkins GA, Ainsworth DM. The effect of adding oral dexamethasone to feed alterations on the airway cell inflammatory gene expression in stabled horses affected with recurrent airway obstruction. J. vet. intern. Med. 2008, 22:427-435.
11. Dowling PM, Williams MA, Clark TP. Adrenal insufficiency associated with long-term anabolic steroid administration in a horse. J. Am. vet. med. Ass. 1993, 203:1166-1169.
12. Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, Diederich S, Bahr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: A comparison of their glucocorticoid and mineralocorticoid properties. Eur. J. Endocrinol. 2004, 151:397-406.
13. Jackson CA, Berney C, Jefcoat AM, Robinson NE. Environment and prednisone interactions in the treatment of recurrent airway obstruction (heaves). Equine vet. J. 2000, 32:432-438.
14. Jean D, Vrins A, Lavoie JP. Monthly, daily, and circadian variations of measurements of pulmanory mechanics in horses with chronic obstructive pulmanory disease. Am. J. vet. Res. 1999, 60:1341-1346.
15. Johnson PJ, Slight SH, Ganjam VK, Kreeger JM. Glucocorticoids and laminitis in the horse. Vet. Clin. N. Am.: Equine Pract. 2002, 18:219-236.
16. Léguillette R. Recurrent airway obstruction - heaves. Vet. Clin. N. Am. Equine Pract. 2003, 19:63-86.
17. Melby JC. Clinical pharmacology of systemic corticosteroids. Ann Rev. Pharmacol. Toxicol. 1977, 17:511-527.
18. Peroni DL, Stanley S, Kollias-Baker C, Robinson NE. Prednisone per os is likely to have limited efficacy in horses. Equine vet. J. 2002, 34:283-287.
19. Picandet V, Léguillette R, Lavoie JP. Comparison of efficacy and tolerability of isoflupredone and dexamethasone in the treatment of horses affected with recurrent airway obstruction ('heaves'). Equine vet. J. 2003, 35:419-424.
20. Robinson NE. International workshop on equine chronic airway disease. Michigan State University 16-18 June 2000. Equine vet. J. 2001, 33:5-19.
21. Robinson NE, Olszewski MA, Boehler D, Berney C, Hakala J, Matson C, Derksen FJ. Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine vet. J. 2000, 32:393-400.
22. Rush BR, Worster AA, Flaminio MJB, Matson CJ, Hakala JE. Alteration in adrenocortical function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. vet. Res. 1998, 59:1044-1047.
23. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell. Endocrinol. 2007, 275:71-78.
24. Toutain PL, Brandon RA, de Pomyers H, Alvinerie M, Baggot JD. Dexamethasone and prednisolone in the horse: Pharmacokinetics and action on the adrenal gland. Am. J. vet. Res. 1984, 45:1750-1756.
25. Walker HJ, Evans DL, Slocombe RF, Hodgson JL, Hodgson DR. Effect of corticosteroid and bronchodilator therapy on bronchoalveolar lavage cytology following intrapulmonary blood inoculation. Equine vet. J., Suppl. 2006, 36:516-522.
26. Williamson KK, Davis MS. Evidence-based respiratory medicine in horses. vet. Clin. N. Am.: Equine Pract. 2007, 23:215-227.